First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
מצבים רפואיים
Breast Cancer · Solid Tumors, Adult
סיכום בשפה פשוטהבעזרת בינה מלאכותית
הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.
מיקומים
Ellison Clinic at Saint John's, Los Angeles, California, United States
Contact: Principal Investigator (Reva Basho)UCSF Medical Center at Mission Bay, San Francisco, California, United States
Contact: Principal Investigator (Varun Monga)University of Colorado Cancer Center, Aurora, Colorado, United States
Contact: Principal Investigator (Anthony Elias)Yale-New Haven Hospital, New Haven, Connecticut, United States
Florida Cancer Specialists ORLANDO/DDU, Lake Mary, Florida, United States
Moffitt Cancer Center, Tampa, Florida, United States
Contact: Principal Investigator (Aixa Soyano)Winship Cancer Institute, Emory University, Atlanta, Georgia, United States
Contact: Principal Investigator (Manali Bhave)University of Iowa, Iowa City, Iowa, United States
Contact: Principal Investigator (Mark Burkard)Louisiana State University Health Sciences Center, New Orleans, Louisiana, United States
Contact: Principal Investigator (Shou-Ching Tang)Massachusetts General Hospital, Boston, Massachusetts, United States
Contact: Principal Investigator (Dejan Juric)Dana-Farber Cancer Institute, Boston, Massachusetts, United States
Contact: Principal Investigator (Antonio Giordano)Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, United States
START Midwest, Grand Rapids, Michigan, United States
Contact: Principal Investigator (Manish Sharma)Saint Luke's Cancer Institute, Kansas City, Missouri, United States
Contact: Principal Investigator (Timothy Pluard)Washington University, St Louis, Missouri, United States
Contact: Principal Investigator (Cynthia Ma)Memorial Sloan Kettering Cancer Center, New York, New York, United States
Contact: Principal Investigator (Komal Jhaveri)UH Cleveland Medical Center, Cleveland, Ohio, United States
Contact: Principal Investigator (Alberto Montero)Stefanie Spielman Comprehensive Breast Center, Columbus, Ohio, United States
Contact: Principal Investigator (Robert Wesolowski)Providence Cancer Institute Franz Clinic, Portland, Oregon, United States
Contact: Principal Investigator (David Page)The West Clinic, PLLC dba West Cancer Center, Germantown, Tennessee, United States
Contact: Principal Investigator (Gregory Vidal)Sarah Cannon Research Institute, Nashville, Tennessee, United States
Contact: Principal Investigator (SMO Sarah Cannon Research Inst.)Mary Crowley Cancer Research Center, Dallas, Texas, United States
Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas, Texas, United States
Contact: Principal Investigator (Joyce O'Shaughnessy)University of Texas Southwestern, Dallas, Texas, United States
Contact: Principal Investigator (Nisha Unni)University of Texas MD Anderson Cancer Center, Houston, Texas, United States
Contact: Principal Investigator (Jordi Rodon Ahnert)START San Antonio, San Antonio, Texas, United States
Contact: Principal Investigator (Amita Patnaik)START Mountain Region, West Valley City, Utah, United States
Contact: Principal Investigator (William McKean)USO-Virginia Cancer Specialists, PC, Fairfax, Virginia, United States
Contact: Principal Investigator (Alexander Spira)Institut Jules Bordet, Anderlecht, Belgium
Contact: Principal Investigator (Philippe Aftimos)UZ Leuven, Leuven, Belgium
Contact: Principal Investigator (Patrick Neven)Institut Bergonié - Centre Régional de Lutte Contre Le Cancer de Bordeaux et Sud Ouest, Bordeaux, France
Contact: Principal Investigator (Maxime Brunet)Centre Leon Berard, Lyon, France
Contact: Principal Investigator (Isabelle Ray-Coquard)Institut Paoli-Calmettes, Marseille, France
Contact: Principal Investigator (Cecile Vicier)Centre Antoine-Lacassagne, Nice, France
Contact: Principal Investigator (Philippe Follana)Institut Claudius Regaud, Toulouse, France
Contact: Principal Investigator (Eleonora De Maio)Gustave Roussy, Villejuif, France
Contact: Principal Investigator (Barbara Pistilli)Universitätsklinikum Erlangen, Erlangen, Germany
Contact: Principal Investigator (Peter Fasching)Mater Misericordiae Hospital, Dublin, Ireland
Contact: Principal Investigator (Austin Duffy)Azienda Ospedaliera Nazionale Santi Antonio e Biagio e Cesare Arrigo, Alessandria, Italy
Contact: Principal Investigator (Giulia Gallizzi)Spedali Civili di Brescia, Brescia, Italy
Contact: Principal Investigator (Rebecca Pedersini)Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy
Contact: Principal Investigator (Giulia Bianchi)Istituto Europeo di Oncologia, Milan, Italy
Contact: Principal Investigator (Giuseppe Curigliano)Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy
Contact: Principal Investigator (Marina Cazzaniga)Azienda Ospedaliero Universitaria Pisana - Stabilimento Santa Chiara, Pisa, Italy
Contact: Principal Investigator (Carmelo Bengala)Ospedale Santa Maria delle Croci, Ravenna, Italy
Contact: Principal Investigator (Stefano Tamberi)Fondazione Policlinico Universitario Agostino Gemelli, Roma, Italy
Contact: Principal Investigator (Gennaro Daniele)Centro Ricerche Cliniche di Verona s.r.l., Verona, Italy
Contact: Principal Investigator (Andrea Zivi)National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan
Contact: Principal Investigator (Eriko Tokunaga)Kansai Medical University Hospital, Hirakata, Japan
Contact: Principal Investigator (Toshio Shimizu)The Cancer Institute Hospital of JFCR, Kōtō City, Japan
Contact: Principal Investigator (Yukinori Ozaki)Kyoto University Hospital, Kyoto, Japan
Contact: Principal Investigator (TAKAKO NAKAJIMA)Netherlands Cancer Institute, Amsterdam, Netherlands
Contact: Principal Investigator (Marloes G.J. van Dongen)Erasmus MC, Rotterdam, Netherlands
Contact: Principal Investigator (Agnes Jager)Hospital Quiron Barcelona, Barcelona, Spain
Contact: Principal Investigator (Guzman Alonso Casal)South Texas Accelerated Research Therapeutics (START) Barcelona- HM Nou Delfos, Barcelona, Spain
Contact: Principal Investigator (Tatiana Hernandez Guerrero)Instituto Oncologico Dr Rosell (IOR), Barcelona, Spain
Contact: Principal Investigator (Jose Manuel Perez Garcia)Hospital Universitari Vall d'Hebron, Barcelona, Spain
Contact: Principal Investigator (Cristina Saura Manich)Hospital San Pedro, Logroño, Spain
Contact: Principal Investigator (Maria Jose de Miguel Luken)MD Anderson Cancer Center, Madrid, Spain
Contact: Principal Investigator (Maria Calvo Plaza)Hospital Clinico San Carlos, Madrid, Spain
Contact: Principal Investigator (Jorge Bartolome Arcilla)Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain
Contact: Principal Investigator (Bernard Doger de Speville Uribe)Hospital Universitario HM Sanchinarro, Madrid, Spain
Contact: Principal Investigator (Juan Jose Soto)Hospital Universitario Quironsalud Madrid, Pozuelo de Alarcón, Spain
Contact: Principal Investigator (Valentina Boni)Hospital Universitari Sant Joan de Reus, Reus, Spain
Contact: Principal Investigator (Kepa Amillano Parraga)Hospital Universitario Virgen Macarena, Seville, Spain
Contact: Principal Investigator (Luis de la Cruz Merino)
מובילי המחקר
Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 8 AM - 8 PM Eastern time (UTC/GMT - 5 hours, EST)
Study Director
Eli Lilly and Company